KB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Challenges, Progresses, and Promises for Developing Future NADPH Oxidase Therapeutics | Antioxidants & redox signaling | 2015 | 522 | 1 | |||
| Cell-free screening for NOX inhibitors | Chemistry & biology | 2012 | 630 | 1 | |||
| Extensive natural variation for cellular hydrogen peroxide release is genetically controlled | PloS one | 2012 | 761 | 506 | |||
| NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action | British journal of pharmacology | 2011 | 750 | 0 | |||
| Calnexin deficiency leads to dysmyelination | The Journal of biological chemistry | 2010 | 622 | 0 | |||
| NOX4 expression in human microglia leads to constitutive generation of reactive oxygen species and to constitutive IL-6 expression | Journal of innate immunity | 2009 | 716 | 4 | |||
| Three common polymorphisms in the CYBA gene form a haplotype associated with decreased ROS generation | Human mutation | 2009 | 671 | 0 | |||
| Editorial: Genetic mapping--the path of discovery for novel functions of the NOX NADPH oxidases | Journal of leukocyte biology | 2009 | 514 | 0 | |||
| NADPH oxidase 1 deficiency alters caveolin phosphorylation and angiotensin II-receptor localization in vascular smooth muscle | Antioxidants & redox signaling | 2009 | 596 | 0 | |||
| NOX enzymes in immuno-inflammatory pathologies | Seminars in immunopathology | 2008 | 620 | 232 | |||
| The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology | Physiological reviews | 2007 | 1,497 | 0 | |||
| NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation | Biochemical journal | 2007 | 674 | 0 | |||
| NOX5 is expressed at the plasma membrane and generates superoxide in response to protein kinase C activation | Biochimie | 2007 | 702 | 0 | |||
| NOX family NADPH oxidases: not just in mammals | Biochimie | 2007 | 855 | 0 |
